About two cases of mycobacterium simiae infection in aids: Review of the pathogenicity

Acta Clinica Belgica

Volumn 53, Issue 3, 1998, Pages 206-212

  Vandercam, B ^a   Gala, J L ^a,b   Gerain, J ^a   Degraux, J ^a   Bourlond, A ^a   Colebunders, B ^c   Pirard, C ^a   Portaels, F ^c  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b Sect Oper Epidemiol Infect Dis

^c INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CLOFAZIMINE; COTRIMOXAZOLE; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BACTERIUM ISOLATION; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; HUMAN; HUMAN TISSUE; LUNG INFECTION; LYMPHOCYTE COUNT; MALE; MYCOBACTERIOSIS; PATHOGENICITY; TREATMENT OUTCOME;

EID: 0031849774     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1080/17843286.1998.11754166     Document Type: Article

References (60)

1. Hopewell P. Impact of human immunodeficiency virus infection on the epidemiology, clinical features, management and control of tuberculosis. Clin Infect Dis. 1992, 15: 540-7.
2. Young LS. Mycobacterium avium complex infection. J Infect Dis. 1988; 157:863-7.
3. Barnes PF, Bloch AB, Davidson PT, Snider DE. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med. 1991: 23; 1644-9.
4. Horsburgh CR. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med. 1991; 23: 1332-8.
5. Portaels F. Le SIDA et les mycobactéries atypiques. Ann Soc Belg Med Trop. 1987; 67: 93-116.
6. Valero G, Peters J, Jorgensen JH, Graybill JR. Clinical isolates of Mycobacterium simiae in San Antonio, Texas. An 11 year review. Am J Respir Crit Care Med. 1995; 152:1555-7.
7. Walker M, Hannah JB. Mycobacterium avium complex infection in patients with the acquired immunodeficiency syndrome. Chest. 1988; 93: 926-32.
8. Nightingale SD, Byrd LT, Southern PM, Jockusch JD, Cal SX, Wynne BA. Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus positive patients. J Infect Dis. 1992; 165: 1082-5.
9. Wayne LG, Sramek HA. Agents of newly recognized or infrequently encountered mycobacterial diseases. Clin Microbiol Rev. 1992; 5: 1-25.
10. Good RC. Opportunistic pathogens in the genus Mycobacterium. Am Rev Microbiol. 1985; 39: 347-69
11. Torres RA, Nord J, Feldman RA, Labombardi V, Barr M. Disseminated mixed Mycobacterium simiae-Mycobacterium avium complex infection in Acquired Immunodeficiency Syndrome. J Infect Dis. 1991; 164: 432-3.
12. Lévy-Frébault V, Pangon B, Burd A, Katlama C, Marche C, David HL. Mycobacterium simiae and Mycobacterium avium-M. intracellulare mixed infection in Acquired Immunodeficiency Syndrome. J Clin Microbiol. 1987; 25: 154-7.
13. Jenkins PA, Pattyn SR, Portaels F. 1982. Diagnostic bacteriology, p 441-469. In: C. Ratledge and JL. Stanford (ed). The biology of the mycobacteria. Academic Press, Inc (London), Ltd, London.
14. Wayne LG. The atypical mycobacteria: recognition and disease association. Crit Rev Microbiol. 1985; 12: 185-222.
15. Canetti G, Wallace Fox, Khomenko A, Mahler HT, Menon NK, Mitchison DA, Rist N, Smelev NA. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull Wld Hlth Org. 1969; 41: 21-43.
16. Daffé M, Lanéelle MA, Asselineau C, Lévy-Frébault V and David HL. Intérêt taxonomique des acides gras des mycobactéries: proposition d'une méthode d'analyse. Ann Microbiol (Paris). 1983; 134 B: 241-56.
17. Dobson G, Minnikin DE, Minnikin SM, Parlett M Goodfellow M. Systematic analysis of complex mycobacterial lipids. Chemical methods in bacterial systematics. Academic Press, Inc (London), Ltd., London. 1983.
18. Lévy-Frébault V, Goh KS, David HL. Mycolic acid analysis for clinical identification of Mycobacterium avium and related mycobacteria. J Clin Microbiol. 1986; 24: 835-9.
19. Jimenez J, Larsson L. Heating cells in acid methanol for 30 min without freeze-drying provides adequate yields of fatty acids and alcohols for gas Chromatographic characterization of mycobacteria. J Clin Microbiol. 1986; 24: 844-5.
20. Portaels F, Dawson DJ, Larsson L, Rigouts L. Biochemical properties and fatty acid composition of Mycobacterium haemophilum: study of 16 isolates from Australian patients. J Clin Microbiol. 1993, 31: 26-30.
21. Karassova V, Weissfeiler J, Krasznay E. Occurrence of atypical mycobacteria in Macacus Rhesus. Acta Microbiol Acad Sci Hung. 1965; 12: 275-82.
22. Boisvert H. Mycobactéries (M. bovis et atypiques) identifiées à I'Institut Pasteur de Paris de 1960 à 1972. Ann Soc Belg Med Trop. 1973; 53: 315-20.
23. Hoffner SE. Pulmonary infections caused by less frequently encountered slow-growing environmental mycobacteria. Eur J Clin Microbiol Infect Dis. 1994; 13(11): 937-41.
24. Boisvert H, Truffot C. Relations entre Mycobacterium simiae et le complexe M. avium intracellulare-scrofulaceum. Ann Microbiol (Inst Pasteur) 1979; 130 B: 457-66.
25. Shyabhaya N, Wongwatana S. Pulmonary infection caused by atypical mycobacteria: a report of 24 cases in Thailand. Rev Infect Dis. 1981; 3: 1085-89.
26. O'Brien RJ, Geiter LJ, Snider DE Jr. The epidemiology of nontuberculous mycobacterial diseases in the United States. Am Rev Respir Dis. 1987; 135: 1007-14.
27. Good RC. Isolation of nontuberculous mycobacteria in the United States, 1979. J Infect Dis. 1980; 142: 779-83.
28. Good RC, Snider DE Jr. Isolation of nontuberculous mycobacteria in the United States, 1980. From the Centers for disease control. J Infect Dis. 1982; 146: 829-33.
29. Valdivia JA. Mycobacterium habana: clinical and epidemiological significance. Ann Soc Belg Med Trop. 1973; 53: 263-6.
30. Lavy A, Yoshpe-Flurer Y. Isolation of Mycobacterium simiae from clinical specimens in Israel. Tubercle. 1982; 63: 279-85.
31. Lavy A, Rusu R, Shaheen S. Mycobacterium aviumintracellulare in clinical specimens etiological factor or contaminant. Isr J Med Sci. 1990; 26: 374-8.
32. Matthews JH, Warren NG. Mycobacterium simiae. Am Rev Respir Dis. 127: 788-9.
33. Portaels F, Walsh GP, De Ridder K, Malaty R, Silva MT, Blinford CH, Meyers WM. Cultivable mycobacteria isolated from 32 newly captured armadillos (Dasypus novemcinctus) from Louisiana. Intern J Leprosy. 1987; 55 (4): 788.
34. Schroder KH, Kazda J, Muller K, Muller H.J. Isolation of Mycobacterium simiae from the environment. Int J Med Microbiol Virol Parasitol Infect Dis. 1992; 277(4): 561-4.
35. Portaels F, Larrson L, Smeets P. Isolation of mycobacteria from healthy person's stools. Intern J Leprosy. 1988; 56: 468-71.
36. Mori T. Acid-fast bacilli detected in umbilical cords and skins of human at cases of surgical operation. Jap J Leprosy. 1990,;59: 98-112.
37. Krasnow I, Gross W. Mycobacterium simiae infection in the United States. Am Rev Respir Dis. 1975; 111: 357-60.
38. Yuc WY, Cohen SS. Pulmonary infection caused by niacin-positive Mycobacterium kansasii. Am Rev Respir Dis. 1966; 94: 447-9.
39. Bell RC, Higuchi JH, Donovan WN, Krasnow I, Johanson WG. Mycobacterium simiae Clinical features and follow-up of 24 patients. Am Rev Respir Dis. 1983; 127: 35-8.
40. Ménard O, Tanguy B, Ahmed Z, Caligaris P, Desnanot J. Mycobactériose pulmonaire grave à Mycobacterium simiae. Rev Mal Resp. 1987; 4: 327-9.
41. Donovan WN, Krasnow I, Donowho EM, Johanson WG. Mycobacterium simiae. Am Rev Respir Dis. 1976; 113: 55 (abstr).
42. Wallace RJ Jr, Glassroth J, Griffith DE, Olivier KN, Cook JL, Gordin F. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med. 1997; 156: S21-S25.
43. Rose HD, Dorff GJ, Lauwasser M, Sheth NK. Pulmonary and disseminated Mycobacterium simiae infection in humans. Am Rev Respir Dis. 1982; 126: 1110-13.
44. Kuipers EJ, Hazenberg HJA, Ploeger B, Smit FW, de Jong A. Nontuberculous mycobacterial sternal osteomyelitis in a patient without predisposing condition. Neth J Med. 1991; 38: 122-5.
45. Heap BJ. Mycobacterium simiae as a cause of intraabdominal disease: a case report. Tubercle. 1989; 70: 217-21.
46. B. Vandercam, LL. Gala, A. Bourlond, B. Vandeweghe, J. De Graux, G. Wauters, L. Larsson, F. Portaels. Mycobacterium simiae disseminated infection in a patient with acquired immunodeficiency syndrome. Infection 1996; 24 (1): 49-51.
47. Friedman BF, Edwards D, Kirkpatrick CH. Mycobacterium avium-intracellulare: cutaneous presentations of disseminated disease. AmJ Med. 1988; 85: 257-63.
48. Woods GL, Washington JA. Mycobacteria other than Mycobacterium tuberculosis : review of microbiologic and clinical aspects. Rev Infect Dis. 1987; 9: 275-94.
49. Wolinsky E. Mycobacterial diseases other than tuberculosis. Clin Infect Dis. 1992; 15: 1-10.
50. Santa Cruz DJ, Strayer DS. The histologic spectrum of the cutaneous mycobacteriosis. Hum Pathol. 1982; 13: 484-95.
51. Horsburgh CR Jr, Mason UG, Farhi DC, Iseman MD. Disseminated infection with Mycobacterium avium-intracellulare. Medicine. 1985; 64: 36-48.
52. Klatt EC, Jensen DF, Meyer PR. Pathology of Mycobacterium avium-intracellulare infection in Acquired Immunodeficiency Syndrome. Hum Pathol. 1987; 18: 709-14.
53. Wallace JM, Hannah JB. Mycobacterium avium complex infection in patients with the Acquired Immunodeficiency Syndrome. A clinicopathologic study. Chest. 1988; 93: 926-32.
54. Wayne LG, Good RC, Krichevsky MI, Blacklock Z, David HL, Dawson D, Gross W, Hawkins J, Lévy-Frébault V, McManus C, Portaels F, Rüsch-Gerdes S, Schröder KH, Silcox VA, Tsukamura M, Van den Breen L, Yakrus MA. Fourth report of the cooperative, open ended study of slowly growing mycobacteria by the International Working Group on Mycobacterial Taxonomy, Int J Syst Bacteriol. 1991; 41: 463-72.
55. Böttger EC, Teske A, Kirschner P, Bost S, Chang HR, Beer V, Hirschel B. Disseminated Mycobacterium genavense infection in patients with AIDS. Lancet. 1992; 340: 76-80.
56. Coyle MB, Carlson LDC, Wallis CK, Leonard RB, Raisys VA, Kiiburn JO, Samadpour M, Böttger E. Laboratory aspects of Mycobacterium genavense, a proposed species isolated from AIDS patients. J Clin Microbiol. 1992; 30: 3206-12.
57. Horsburgh CR. Advances in the prevention and treatment of Mycobacterium avium disease. N Engl J Med. 1996; 335: 426-30.
58. Shafran SD, Singer J, Zarowny P et al. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS; Rifabutin, Ethambutol and clarithromycin versus Rifampin, Ethambutol, Clofazimine and Ciprofloxacin. N Engl J Med . 1996; 335: 377-83.
59. Valero G, Moreno F, Graybill JR. Activities of clarithromycin, ofloxacin and clarithromycin plus ethambutol against Mycobacterium simiae in a murine model of disseminated infection. Antimicrob Agents Chemother. 1994; 38(11): 2676-7.
60. Watson SR, Auclair LK, Collins SM. The effect of combined chemotherapy on suppressor T-cell activity in Mycobacterium simiae infected mice. Immunology. 1981; 43 :459-65.